US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 53.910
- +0.180+0.34%
Close Apr 26 16:00 ET
- 54.110
- +0.200+0.37%
Post 19:59 ET
4.58BMarket Cap-27788P/E (TTM)
54.935High52.814Low1.35MVolume54.210Open53.730Pre Close73.21MTurnover1.62%Turnover RatioLossP/E (Static)84.88MShares91.10052wk High2.43P/B4.49BFloat Cap37.55052wk Low--Dividend TTM83.37MShs Float220.200Historical High--Div YieldTTM3.95%Amplitude11.630Historical Low54.087Avg Price1Lot Size
CRISPR Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Apr 18, 2024
The average CRISPR Therapeutics stock price target is 79.60 with a max estimate of 112.00 and a min estimate of 30.00
Review CRISPR Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Apr 18, 2024
Heat List
US
Overall
Symbol
Latest Price
%Chg
